[EN] QUINOLIZINONE DERIVATIVES AS PI3K INHIBITORS<br/>[FR] DÉRIVÉS DE QUINOLIZINONE UTILISÉS COMME INHIBITEURS DE PI3K
申请人:LUPIN LTD
公开号:WO2017103825A1
公开(公告)日:2017-06-22
Disclosed are compounds of formula (I), their tautomeric forms, stereoisomers, and pharmaceutically acceptable salts thereof (I), wherein R1-R5, and n are as defined in the specification, pharmaceutical compositions including a compound, tautomer, stereoisomer, or salt thereof, and methods of treating or preventing diseases or disorders, for example, cancer, that are amenable to treatment or prevention by inhibiting the PI3K enzyme of a subject.